Page last updated: 2024-09-03

celastrol and Cancer of Head

celastrol has been researched along with Cancer of Head in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dannenberg, AJ; Guttenplan, JB; Hughes, D; Marcus, CB; Subbaramaiah, K	1

Other Studies

1 other study(ies) available for celastrol and Cancer of Head

Article	Year
Heat shock protein 90 inhibitors suppress aryl hydrocarbon receptor-mediated activation of CYP1A1 and CYP1B1 transcription and DNA adduct formation. Cancer prevention research (Philadelphia, Pa.), 2008, Volume: 1, Issue:6 Topics: Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Benzoquinones; Carcinoma, Squamous Cell; Cells, Cultured; Chemoprevention; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; DNA Adducts; Drug Evaluation, Preclinical; Enzyme Activation; Gene Expression Regulation, Enzymologic; Head and Neck Neoplasms; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Models, Biological; Pentacyclic Triterpenes; Precancerous Conditions; Receptors, Aryl Hydrocarbon; Transcription, Genetic; Triterpenes	2008

Article

Year

Heat shock protein 90 inhibitors suppress aryl hydrocarbon receptor-mediated activation of CYP1A1 and CYP1B1 transcription and DNA adduct formation.

Cancer prevention research (Philadelphia, Pa.), 2008, Volume: 1, Issue:6

Topics: Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Benzoquinones; Carcinoma, Squamous Cell; Cells, Cultured; Chemoprevention; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; DNA Adducts; Drug Evaluation, Preclinical; Enzyme Activation; Gene Expression Regulation, Enzymologic; Head and Neck Neoplasms; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Models, Biological; Pentacyclic Triterpenes; Precancerous Conditions; Receptors, Aryl Hydrocarbon; Transcription, Genetic; Triterpenes

2008